MedPath

One Session Virtual Reality During Ongoing Treatment for Anxiety: Feasibility in Children and Adolescents

Not Applicable
Not yet recruiting
Conditions
Anxiety Disorders
Exposure
Social Anxiety Disorder
Interventions
Behavioral: One session exposure with Virtual Reality
Registration Number
NCT06338800
Lead Sponsor
Accare
Brief Summary

The goal of this study is to evaluate one session with exposure with Virtual Reality (VR) in in children and adolescents, aged 8-18 years with an anxiety disorder. The main questions it aims to answer are:

1. What are the expectations of children and adolescents and therapists with VR exposure?

2. What is the acceptability of the VR session (positive and negative effects)?

3. What are possible working mechanisms of VR exposure? During ongoing treatment, participants will receive a session of exposure with VR.

Detailed Description

Cognitive behavioral therapy is an effective treatment for anxiety disorders, with exposure as the most important working ingredient. Exposure therapy can be challenging to implement in face-to-face settings. Virtual reality (VR) has emerged as a promising tool for delivering exposure therapy.

In the current study, the researchers will examine children and adolescents that will participate in a single session of VR exposure during their regular treatment (n=30). Willingness to participate in exposure in vivo will be assessed directly before and directly after the session. During the session anxiety, idiosyncratic expectations, and self-efficacy will be assessed. Expectations will be measured before the session and acceptability after the session.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Children and adolescents 8-18 years old.
  • Meeting Diagnostic and Statistical Manual of Mental Disorders -5 criteria for an anxiety disorder, based on a semi-structured interview (SCID-5 Jr, specific section) or clinical judgment of an experienced and authorized clinician.
Exclusion Criteria
  • Severe psychiatric symptoms other than anxiety disorder interfering with safety or warranting immediate intervention, e.g. psychosis or acute suicidality.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
One session VR ExposureOne session exposure with Virtual RealityAll participants will receive one session exposure therapy with virtual reality during ongoing treatment.
Primary Outcome Measures
NameTimeMethod
Willingness to participate in exposure in vivoDirectly before and immediately after the session

Participants will be asked about their willingness to participate in exposure in vivo

Secondary Outcome Measures
NameTimeMethod
Idiosyncratic expectationsDuring the session

Specific idiosyncratic expectations of the children and the adolescents, rated on a likert scale ranging from 0-10 (a higher score is a stronger belief).

AnxietyDuring the session

Anxiety of the children and adolescents will be rated on a likert-scale, subjective units of distress (SUD-scores) ranging from 0-10 (a higher score is more anxiety).

AcceptabilityImmediately after the session

Acceptability of virtual reality exposure will be assessed with a questionnaire specifically designed for this study. Youth will be asked about positive and negative effects and their experiences.

Expectations of Virtual RealityDirectly before the session

Expectations of the session with virtual reality will be assessed with the Credibility and Expectancy Questionnaire for therapists and children.

© Copyright 2025. All Rights Reserved by MedPath